ArticleFrontiers in medicine2026
Clinical characteristics and factors associated with different BASP subtypes of androgenetic alopecia.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to explore the associated factors for different basic and specific (BASP) classification subtypes of androgenic alopecia (AGA). Methods: This retrospective case-control study included patients diagnosed with AGA in the Department of Dermatology of our hospital between May 2018 and June 2024 and healthy individuals undergoing routine physical examination during the same period. Ultimately, 1,505 patients with AGA and 1,751 healthy controls were enrolled. AGA was classified into M-, C-, U-, F-, and V-type according to the BASP classification system. Baseline differences between the AGA and control groups were first assessed using univariate analyses. Given the multiple comparisons involved, Bonferroni correction was applied to the univariate analyses. Subsequently, multivariable logistic regression was performed to identify factors independently associated with overall AGA, and multivariable regression analyses were further conducted to determine factors independently associated with the severity of each BASP subtype. Results: Compared with healthy controls, patients with AGA were more likely to be male, older, and smokers and to have a parental history of hair loss, higher BMI, shorter shampooing intervals, scalp oiliness, a high-fat diet, heart disease, hyperlipidemia, fatty liver, lower serum 25-hydroxyvitamin D [25(OH)D] levels, and higher homocysteine (Hcy) levels. In multivariable logistic regression, male sex, age, smoking, paternal and maternal hair loss history, BMI, shampooing interval ≤1 day, scalp oiliness, high-fat diet, heart disease, hyperlipidemia, fatty liver, lower 25(OH)D, and higher Hcy remained independently associated with AGA. In multivariable analyses of BASP subtype severity, age, father's hair loss history, high-fat diet, lower 25(OH)D, and higher Hcy were consistently associated with severity across all five BASP subtypes. Additional subtype-specific associations were also observed, including male sex for M-, U-, and F-type; drinking for U-, F-, and V-type; hypertension for U- and V-type; diabetes for F-type; hyperlipidemia for F- and V-type; and fatty liver for U-type. Conclusion: Several demographics, familial, lifestyle, and metabolic factors were independently associated with overall AGA, and both shared and subtype-specific associations were identified for the severity of different BASP subtypes. These findings may help inform clinical assessment and future hypothesis generation; however, prospective studies are still required before these associations can be interpreted in a temporal or causal framework.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.